These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 7707119

  • 1. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma.
    Harrison M, Tomlinson D, Stewart S.
    J Clin Oncol; 1995 Apr; 13(4):914-20. PubMed ID: 7707119
    [Abstract] [Full Text] [Related]

  • 2. Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma.
    Simpson JK, Miller RF, Spittle MF.
    Clin Oncol (R Coll Radiol); 1993 Apr; 5(6):372-4. PubMed ID: 8305358
    [Abstract] [Full Text] [Related]

  • 3. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
    Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH, Jacobs M, Kempin S, Silverberg I, Gonzales G, Rarick MU, Myers AM, Shepherd F, Sawka C, Pike MC, Ross ME.
    J Clin Oncol; 1996 Aug; 14(8):2353-64. PubMed ID: 8708728
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy.
    Northfelt DW, Dezube BJ, Thommes JA, Levine R, Von Roenn JH, Dosik GM, Rios A, Krown SE, DuMond C, Mamelok RD.
    J Clin Oncol; 1997 Feb; 15(2):653-9. PubMed ID: 9053490
    [Abstract] [Full Text] [Related]

  • 5. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
    Cheung TW, Remick SC, Azarnia N, Proper JA, Barrueco JR, Dezube BJ.
    Clin Cancer Res; 1999 Nov; 5(11):3432-7. PubMed ID: 10589755
    [Abstract] [Full Text] [Related]

  • 6. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
    Gill PS, Tulpule A, Espina BM, Cabriales S, Bresnahan J, Ilaw M, Louie S, Gustafson NF, Brown MA, Orcutt C, Winograd B, Scadden DT.
    J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228
    [Abstract] [Full Text] [Related]

  • 7. Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS.
    James ND, Coker RJ, Tomlinson D, Harris JR, Gompels M, Pinching AJ, Stewart JS.
    Clin Oncol (R Coll Radiol); 1994 Jun; 6(5):294-6. PubMed ID: 7530036
    [Abstract] [Full Text] [Related]

  • 8. Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi sarcoma.
    Bogner JR, Kronawitter U, Rolinski B, Truebenbach K, Goebel FD.
    J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):463-8. PubMed ID: 8158540
    [Abstract] [Full Text] [Related]

  • 9. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.
    Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM.
    J Clin Oncol; 1995 Apr; 13(4):996-1003. PubMed ID: 7707129
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
    Cooley T, Henry D, Tonda M, Sun S, O'Connell M, Rackoff W.
    Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906
    [Abstract] [Full Text] [Related]

  • 11. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.
    Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA, Friedman-Kien A, Kaplan LD, Du Mond C, Mamelok RD, Henry DH.
    J Clin Oncol; 1998 Jul; 16(7):2445-51. PubMed ID: 9667262
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group.
    Goebel FD, Goldstein D, Goos M, Jablonowski H, Stewart JS.
    Br J Cancer; 1996 Apr; 73(8):989-94. PubMed ID: 8611437
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma.
    Tulpule A, Yung RC, Wernz J, Espina BM, Myers A, Scadden DT, Cabriales S, Ilaw M, Boswell W, Gill PS.
    J Clin Oncol; 1998 Oct; 16(10):3369-74. PubMed ID: 9779714
    [Abstract] [Full Text] [Related]

  • 14. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma: long-term experiences.
    Wagner D, Kern WV, Kern P.
    Clin Investig; 1994 Jun; 72(6):417-23. PubMed ID: 7950152
    [Abstract] [Full Text] [Related]

  • 15. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma.
    Coukell AJ, Spencer CM.
    Drugs; 1997 Mar; 53(3):520-38. PubMed ID: 9074848
    [Abstract] [Full Text] [Related]

  • 16. Pulmonary Kaposi's sarcoma in AIDS patients treated with combined chemotherapy and recombinant human granulocyte colony-stimulating factor.
    Mastroianni A, Coronado O, Cancellieri C, Manfredi R, Pignatari S, Chiodo F.
    J Chemother; 1998 Oct; 10(5):405-10. PubMed ID: 9822360
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
    Stein ME, Lachter J, Spencer D, Bezwoda WR.
    Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.